113 related articles for article (PubMed ID: 11901229)
1. Cytochrome P450 3A conjugation to ubiquitin in a process distinct from classical ubiquitination pathway.
Zangar RC; Kimzey AL; Okita JR; Wunschel DS; Edwards RJ; Kim H; Okita RT
Mol Pharmacol; 2002 Apr; 61(4):892-904. PubMed ID: 11901229
[TBL] [Abstract][Full Text] [Related]
2. Suppression of cytochrome P450 3A protein levels by proteasome inhibitors.
Zangar RC; Kocarek TA; Shen S; Bollinger N; Dahn MS; Lee DW
J Pharmacol Exp Ther; 2003 Jun; 305(3):872-9. PubMed ID: 12626652
[TBL] [Abstract][Full Text] [Related]
3. Evidence of proteasome-mediated cytochrome P-450 degradation.
Roberts BJ
J Biol Chem; 1997 Apr; 272(15):9771-8. PubMed ID: 9092510
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome?
Korsmeyer KK; Davoll S; Figueiredo-Pereira ME; Correia MA
Arch Biochem Biophys; 1999 May; 365(1):31-44. PubMed ID: 10222036
[TBL] [Abstract][Full Text] [Related]
5. Hydroperoxy-10,12-octadecadienoic acid stimulates cytochrome P450 3A protein aggregation by a mechanism that is inhibited by substrate.
Kimzey AL; Weitz KK; Guengerich FP; Zangar RC
Biochemistry; 2003 Nov; 42(43):12691-9. PubMed ID: 14580217
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
7. Involvement of cytochrome P450 3A in the metabolism and covalent binding of 14C-monocrotaline in rat liver microsomes.
Reid MJ; Lamé MW; Morin D; Wilson DW; Segall HJ
J Biochem Mol Toxicol; 1998; 12(3):157-66. PubMed ID: 9522275
[TBL] [Abstract][Full Text] [Related]
8. Ethosuximide is primarily metabolized by CYP3A when incubated with isolated rat liver microsomes.
Sarver JG; Bachmann KA; Zhu D; Klis WA
Drug Metab Dispos; 1998 Jan; 26(1):78-82. PubMed ID: 9443857
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes.
Wang HF; Figueiredo Pereira ME; Correia MA
Arch Biochem Biophys; 1999 May; 365(1):45-53. PubMed ID: 10222037
[TBL] [Abstract][Full Text] [Related]
10. In-vivo and in-vitro metabolic clearance of midazolam, a cytochrome P450 3A substrate, by the liver under normal and increased enzyme activity in rats.
Higashikawa F; Murakami T; Kaneda T; Takano M
J Pharm Pharmacol; 1999 Apr; 51(4):405-10. PubMed ID: 10385212
[TBL] [Abstract][Full Text] [Related]
11. Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding of inducers to a microsomal protein.
Wright MC; Paine AJ
Biochem Biophys Res Commun; 1994 Jun; 201(2):973-9. PubMed ID: 8003039
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans.
Kashiyama E; Yokoi T; Odomi M; Funae Y; Inoue K; Kamataki T
Drug Metab Dispos; 1997 Jun; 25(6):716-24. PubMed ID: 9193873
[TBL] [Abstract][Full Text] [Related]
13. Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes.
Fontaine F; de Sousa G; Burcham PC; Duchêne P; Rahmani R
Life Sci; 2000 Apr; 66(22):2193-212. PubMed ID: 10834303
[TBL] [Abstract][Full Text] [Related]
14. Posttranscriptional elevation of cytochrome P450 3A expression.
Zangar RC; Hernandez M; Novak RF
Biochem Biophys Res Commun; 1997 Feb; 231(1):203-5. PubMed ID: 9070249
[TBL] [Abstract][Full Text] [Related]
15. Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A.
Voorman RL; Maio SM; Payne NA; Zhao Z; Koeplinger KA; Wang X
J Pharmacol Exp Ther; 1998 Oct; 287(1):381-8. PubMed ID: 9765359
[TBL] [Abstract][Full Text] [Related]
16. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
17. Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine.
Zhang H; Coville PF; Walker RJ; Miners JO; Birkett DJ; Wanwimolruk S
Br J Clin Pharmacol; 1997 Mar; 43(3):245-52. PubMed ID: 9088578
[TBL] [Abstract][Full Text] [Related]
18. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
Goasduff T; Cederbaum AI
Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
[TBL] [Abstract][Full Text] [Related]
19. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
Witherow LE; Houston JB
J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
[TBL] [Abstract][Full Text] [Related]
20. Effects of bioflavonoids on hepatic P450 activities.
Obermeier MT; White RE; Yang CS
Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
